ES2174287T3 - Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo. - Google Patents

Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo.

Info

Publication number
ES2174287T3
ES2174287T3 ES97941921T ES97941921T ES2174287T3 ES 2174287 T3 ES2174287 T3 ES 2174287T3 ES 97941921 T ES97941921 T ES 97941921T ES 97941921 T ES97941921 T ES 97941921T ES 2174287 T3 ES2174287 T3 ES 2174287T3
Authority
ES
Spain
Prior art keywords
treatment
amidas
acid
alcoholism
hydroxibutaric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97941921T
Other languages
English (en)
Spanish (es)
Inventor
Roberto Cacciaglia
Antonella Loche
Vincenzo Perlini
Lorenza Guano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ct Lab Farm Srl
Laboratorio Farmaceutico CT SRL
Original Assignee
Ct Lab Farm Srl
Laboratorio Farmaceutico CT SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Lab Farm Srl, Laboratorio Farmaceutico CT SRL filed Critical Ct Lab Farm Srl
Application granted granted Critical
Publication of ES2174287T3 publication Critical patent/ES2174287T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES97941921T 1996-08-09 1997-08-07 Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo. Expired - Lifetime ES2174287T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001732A IT1283782B1 (it) 1996-08-09 1996-08-09 Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo

Publications (1)

Publication Number Publication Date
ES2174287T3 true ES2174287T3 (es) 2002-11-01

Family

ID=11374795

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97941921T Expired - Lifetime ES2174287T3 (es) 1996-08-09 1997-08-07 Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo.

Country Status (13)

Country Link
US (2) US6436998B1 (enExample)
EP (1) EP0932597B1 (enExample)
JP (1) JP4259615B2 (enExample)
AT (1) ATE215065T1 (enExample)
AU (1) AU4379097A (enExample)
CA (1) CA2263328C (enExample)
DE (1) DE69711411T2 (enExample)
DK (1) DK0932597T3 (enExample)
ES (1) ES2174287T3 (enExample)
HU (1) HU228595B1 (enExample)
IT (1) IT1283782B1 (enExample)
PT (1) PT932597E (enExample)
WO (1) WO1998006690A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2355293C (en) 1998-12-23 2005-08-16 Orphan Medical, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
FR2827859B1 (fr) 2001-07-30 2005-09-23 Lipha Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete
WO2004041207A2 (en) * 2002-11-01 2004-05-21 Baylor Research Institute Ghb treatment methods
US7838556B2 (en) * 2006-02-21 2010-11-23 University Of Maryland, Baltimore Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands
EP2062875A1 (en) * 2007-11-13 2009-05-27 LABORATORIO FARMACEUTICO C.T. S.r.l. New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US8771735B2 (en) * 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
JP5968300B2 (ja) 2010-03-24 2016-08-10 ジャズ、ファーマシューティカルズ、インコーポレイテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 高用量、水溶性及び吸湿性薬剤基質用の制御放出性剤形
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
ITMI20132041A1 (it) * 2013-12-06 2015-06-07 Ct Lab Farm Srl Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico.
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
ITUB20152860A1 (it) * 2015-08-04 2017-02-04 Laboratorio Farm C T S R L Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool
ITUA20164040A1 (it) * 2016-06-01 2017-12-01 Laboratorio Farm C T S R L Procedimento per la preparazione di polimorfo a
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
WO2020106735A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
JP7553453B2 (ja) 2019-03-01 2024-09-18 フラメル アイルランド リミテッド 食事摂取状態における改善された薬物動態を有するガンマ－ヒドロキシ酪酸塩組成物
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
WO2023126076A1 (en) 2022-01-03 2023-07-06 Laboratorio Farmaceutico C.T. S.R.L. Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940258A (en) * 1971-11-26 1976-02-24 Gaf Corporation Method for controlling aquatic weeds with N-phenylalkyl-γ-hydroxybutyramide
JPS6016432B2 (ja) * 1977-07-26 1985-04-25 グレラン製薬株式会社 複素環式化合物類およびその製造法
ES2103287T3 (es) * 1987-02-23 1997-09-16 Ono Pharmaceutical Co Nuevos derivados de tiazolidina.
IT1217783B (it) * 1988-06-03 1990-03-30 Farmaceutico Ct S R L Lab Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
JPH10501238A (ja) * 1994-06-01 1998-02-03 アリス ファーマシューティカル コーポレイション 肥満細胞媒介症状を治療するための組成物及び方法
HUP9602538A3 (en) * 1995-09-18 1997-08-28 Sankyo Co New urea and amide derivatives having acat inhibitory activity, their preparation and their use
KR100572534B1 (ko) * 1997-10-14 2006-04-24 미츠비시 웰파마 가부시키가이샤 피페라진 화합물 및 그 의약으로서의 용도

Also Published As

Publication number Publication date
US6770784B2 (en) 2004-08-03
WO1998006690A1 (en) 1998-02-19
ITMI961732A1 (it) 1998-02-09
JP2000516225A (ja) 2000-12-05
DE69711411D1 (de) 2002-05-02
EP0932597B1 (en) 2002-03-27
JP4259615B2 (ja) 2009-04-30
CA2263328C (en) 2006-07-25
CA2263328A1 (en) 1998-02-19
ATE215065T1 (de) 2002-04-15
HU228595B1 (en) 2013-04-29
DK0932597T3 (da) 2002-06-24
DE69711411T2 (de) 2002-11-07
US20020165224A1 (en) 2002-11-07
HUP9902437A2 (hu) 1999-12-28
ITMI961732A0 (enExample) 1996-08-09
EP0932597A1 (en) 1999-08-04
AU4379097A (en) 1998-03-06
HUP9902437A3 (en) 2001-07-30
PT932597E (pt) 2002-09-30
IT1283782B1 (it) 1998-04-30
US6436998B1 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
ES2174287T3 (es) Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo.
HN1999000124A (es) Derivados de pirazol substituido.
CR6938A (es) Monohidrato cristalino metodo para su fabricacion y su empleo en la fabricacion de un medicamento.
BR9807995A (pt) Derivados de 1,5-diidro-pirazol(3,4-d)-pirimidinona
ECSP034772A (es) Antagonistas de mch y su uso en el tratamiento de obesidad
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
PT1401841E (pt) Derivados substituidos de 1-oxa-2,8-diaza-espiro[4.5]dec-2-eno como medicamentos para o tratamento da dor
CR6735A (es) Substituted arylpyrazines
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
DK0817770T3 (da) Nonpeptider som tachykininantagonister
LTPA2011013I1 (lt) 8-[3-amino-piperidin-1-il]-ksantinai, jų gavimas ir jų panaudojimas, kaip vaistų
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
DOP2005000251A (es) 3-amino-pirazol [3,4b] piridinas como inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
BR9607186B1 (pt) antagonistas de vasopressina de benzazepina tricÍclica, bem como composiÇço farmacÊutica compreendendo os mesmos.
BR9710560B1 (pt) Composição farmacêutica contendo clopidogrel e sinvastatina, bem como seus usos.
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
BR0110832A (pt) Bebida estável ao ambiente, e, método para a preparação de uma bebida a base de chá estável ao ambiente adequada para enchimento a frio
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
WO2003026563A3 (en) Conjugated anti-psychotic drugs and uses thereof
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
ES2062145T3 (es) 1,8-naftiridinas substituidas.
ES2095984T3 (es) 2,3-dihidropirano(2,3-b)piridinas aminometil sustituidas, procedimiento para su preparacion y su uso en medicamentos.
ATE252844T1 (de) Zusammengesetztes, essbares produkt aus mindestens drei getrennten teilen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 932597

Country of ref document: ES